Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
464.00    2.50 (0.54%)
Bid:
462.50
Ask:
464.00
Spread: 1.50 (0.324%)
Market Cap: £161.16m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Director's Dealing

20 Feb 2015 13:32

RNS Number : 4959F
Frontier Developments PLC
20 February 2015
 



20 February 2015

 

Frontier Developments Plc

 

Director's Dealing

 

20 February 2015 - Frontier Developments Plc (AIM: FDEV) (the "Company"), announces the following transaction in ordinary shares of 0.5p each in the Company ("Ordinary Shares") by a Director of the Company.

 

On 20 February 2015, the Company received notification from Mr David Gammon, Non-Executive Chairman of the Company, that he and his wife had provided a guarantee in respect of their son's legal mortgage agreement with Nedbank Private Wealth Limited ("Nedbank") dated 6 February 2015 (the "Guarantee"). The Guarantee is supported by a charge over a portfolio of assets, which includes 5,000 Ordinary Shares held by Mr Gammon and his wife.

 

Mr Gammon and his wife retain the legal title, beneficial ownership and voting rights in respect of these 5,000 Ordinary Shares charged under the Guarantee.

 

Following this transaction, Mr Gammon and family will have the following interests in the Company's share capital:

 

Director

Number of Ordinary Shares prior to this transaction

Number of Ordinary Shares following this transaction

Total number of options

Total interest (Ordinary Shares and options) as % of issued share capital

Rockspring1

286,720

286,720

170,743

1.36%

David Gammon and family2

5,000

5,0003

0

0.01%

 

 

1 Rockspring is an unlimited liability company, in which Mr Gammon and his family are the only shareholders. Mr Gammon and his family are beneficially interested in the shares held by Rockspring

2 Shares jointly owned by David Gammon and his wife

3 David Gammon and his wife continue to retain the legal and beneficial ownership of these shares. However, in the event the obligations under the mortgage were not met, Nedbank could exercise their collateral and sell the 5,000 Ordinary Shares

 

 

Enquiries:

 

Frontier Developments + 44 (0) 1223 394 300

David Braben, CEO

David Walsh, COO

Neil Armstrong, CFO

  

Canaccord Genuity Limited + 44 (0) 207 523 8000

Simon Bridges / Cameron Duncan

 

FinnCap Ltd + 44 (0) 207 220 0506

Charlotte Stranner

 

Tulchan Communications + 44 (0) 207 353 4200

James Macey White

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFEFFFIIFIE
Date   Source Headline
1st Jun 202612:05 pmRNSEBT Share Purchase
28th May 20262:30 pmRNS-RPlanet Zoo 2 Announced
22nd May 202611:26 amRNS-RWarhammer 40,000: Chaos Gate – Deathwatch Revealed
22nd May 20269:16 amRNSHolding(s) in Company
19th May 20265:47 pmRNSHolding(s) in Company
18th May 202610:48 amRNSEBT Share Purchase
12th May 20267:00 amRNSTrading Update - FY26 Revenue & Profit Upgraded
23rd Apr 20267:00 amRNSCompletion of Share Buyback Programme
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 202611:05 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.